Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Lymphoma, Intermediate-Grade”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Active Not RecruitingNCT02051257
What this trial is testing

Memory Enriched T Cells Following Stem Cell Transplant in Treating Patients With Recurrent B-Cell Non-Hodgkin Lymphoma

Who this might be right for
Recurrent Diffuse Large B-Cell LymphomaRecurrent Mantle Cell LymphomaRefractory Diffuse Large B-Cell Lymphoma+2 more
City of Hope Medical Center 51
Large-scale testing (Phase 3)Study completedNCT00003687
What this trial is testing

Treatment for Chronic Pain in Patients With Advanced Cancer

Who this might be right for
Chronic Myeloproliferative DisordersLeukemiaLymphoma+6 more
NCIC Clinical Trials Group 87
Testing effectiveness (Phase 2)WithdrawnNCT00004039
What this trial is testing

Combination Chemotherapy Plus Interferon Alfa or Rituximab in Treating Patients With Stage III or Stage IV Lymphoma

Who this might be right for
Lymphoma
Hoag Memorial Hospital Presbyterian
Testing effectiveness (Phase 2)Study completedNCT01206777
What this trial is testing

Feasibility Study of a 60 Minute Rapid Infusion Rituximab Protocol in Patients With B-cell Malignancies

Who this might be right for
Indolent or Intermediate Grade B-cell Malignancy
Ohio State University Comprehensive Cancer Center 52
Early research (Phase 1)Study completedNCT01300026
What this trial is testing

AMG 319 Lymphoid Malignancy FIH

Who this might be right for
CancerChronic Lymphocytic LeukemiaDiffuse Large Cell Lymphoma+11 more
Amgen 28
Not applicableStudy completedNCT01809600
What this trial is testing

Retrospective Analysis of Rituximab-containing Immunochemotherapy for Burkitt's or Burkitt-like Lymphoma in Adults

Who this might be right for
Burkitt's LymphomaHigh-grade B-cell Lymphoma
Gachon University Gil Medical Center 43
Large-scale testing (Phase 3)UnknownNCT00317096
What this trial is testing

FCM Versus R-FCM Followed by R-Maintenance or Observation Only

Who this might be right for
Lymphoma, FollicularLymphoma, Low-GradeLymphoma, Intermediate-Grade
Ludwig-Maximilians - University of Munich 319
Early research (Phase 1)Study completedNCT03434262
What this trial is testing

SJDAWN: St. Jude Children's Research Hospital Phase 1 Study Evaluating Molecularly-Driven Doublet Therapies for Children and Young Adults With Recurrent Brain Tumors

Who this might be right for
Anaplastic AstrocytomaAnaplastic EpendymomaAnaplastic Ganglioglioma+53 more
St. Jude Children's Research Hospital 68
Testing effectiveness (Phase 2)UnknownNCT00026429
What this trial is testing

Denileukin Diftitox in Treating Patients With Non-Hodgkin's Lymphoma

Who this might be right for
LeukemiaLymphoma
Pharmatech Oncology
Large-scale testing (Phase 3)Study completedNCT00002565
What this trial is testing

Combination Chemotherapy in Treating Patients With Intermediate-Grade or Immunoblastic Non-Hodgkin's Lymphoma

Who this might be right for
Lymphoma
M.D. Anderson Cancer Center 61
Testing effectiveness (Phase 2)Study completedNCT00193505
What this trial is testing

Ifosfamide/Carboplatin/Etoposide/Rituxan Followed by Zevalin in Relapsed/Refractory Intermediate Grade B-Cell Lymphoma

Who this might be right for
Non-Hodgkins Lymphoma
SCRI Development Innovations, LLC 40
Testing effectiveness (Phase 2)Study completedNCT00000801
What this trial is testing

Phase II Trial of Sequential Chemotherapy and Radiotherapy for AIDS-Related Primary Central Nervous System Lymphoma

Who this might be right for
Lymphoma, Non-HodgkinHIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 33
Testing effectiveness (Phase 2)UnknownNCT00002488
What this trial is testing

Combination Chemotherapy in Treating Patients With Intermediate-Grade or High-Grade Non-Hodgkin's Lymphoma Who Have Not Responded to Anthracycline-Containing Combination Chemotherapy

Who this might be right for
Lymphoma
Ottawa Regional Cancer Centre
Early research (Phase 1)Active Not RecruitingNCT03150329
What this trial is testing

Pembrolizumab and Vorinostat in Patients With Relapsed or Refractory DLBCL, FCL or HL.

Who this might be right for
Grade 3b Follicular LymphomaRecurrent B-Cell Lymphoma, Unclassifiable, With Features Intermediate Between DLBCL and Classic HLRecurrent Classic Hodgkin Lymphoma+13 more
City of Hope Medical Center 52
Large-scale testing (Phase 3)Study completedNCT00970385
What this trial is testing

Study About Treatment of Newly Diagnosed Non Cutaneous Peripheral T Cell Lymphoma

Who this might be right for
Peripheral T Cell Lymphoma
University Hospital, Grenoble 95
Large-scale testing (Phase 3)Ended earlyNCT00133302
What this trial is testing

Study of Standard CHOP Versus Biweekly CHOP in Aggressive Non-Hodgkin's Lymphoma (JCOG9809)

Who this might be right for
Non-Hodgkin's Lymphoma
Japan Clinical Oncology Group 450
Testing effectiveness (Phase 2)Study completedNCT00006125
What this trial is testing

Combination Chemotherapy in Treating Patients With Relapsed or Refractory Intermediate-Grade or High-Grade Non-Hodgkin's Lymphoma

Who this might be right for
Lymphoma
Alliance for Clinical Trials in Oncology
Testing effectiveness (Phase 2)Study completedNCT00045864
What this trial is testing

Proleukin in Combination With Rituxan in Patients With Intermediate and High-Grade Non-Hodgkin's Lymphoma.

Who this might be right for
Lymphoma, Non-Hodgkin
Chiron Corporation
Testing effectiveness (Phase 2)Study completedNCT00005040
What this trial is testing

Arsenic Trioxide in Treating Patients With Relapsed or Refractory Non- Hodgkin's Lymphoma

Who this might be right for
Lymphoma
Memorial Sloan Kettering Cancer Center
Early research (Phase 1)Study completedNCT00709033
What this trial is testing

T-cells or EBV Specific CTLs, Advanced B-Cell NHL and CLL

Who this might be right for
Non-Hodgkin LymphomaChronic Lymphocytic Leukemia
Baylor College of Medicine 3
Next Page